Status:
UNKNOWN
Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning
Lead Sponsor:
I.M. Sechenov First Moscow State Medical University
Conditions:
Breast Cancer
Postsurgical Acquired Absence of Organ
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the efficacy and safety of contrast-free magnetic resonance angiography (MRA) for deep inferior epigastric perforator flap planning. The investigators propose to p...
Detailed Description
Rationale. Contrast-free MRA is a new concept for preoperative planning in breast reconstruction that combines the advantages of magnetic resonance imaging (no ionising radiation exposure), requires n...
Eligibility Criteria
Inclusion
- A female patients who underwent unilateral mastectomy due to breast cancer, in remission.
- At least 1 year after completion of radiotherapy.
- Non-inclusion Criteria:
- A history of abdominal donor site free flaps or abdominoplasty.
- Inability to give consent.
- The expander with magnetic ports, claustrophobia, pregnancy and breastfeeding.
- Patients with severe hypertension, COPD, autoimmune disorders, SLE or poorly regulated diabetes
- The presence of psychiatric illness preventing participation in the study.
Exclusion
- Patient's pregnancy diagnosed during the research period.
- Patient's refusal of surgery, patient's refusal of further participation in the study.
- The presence of concomitant diseases preventing participation in the study.
Key Trial Info
Start Date :
May 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2024
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT06061835
Start Date
May 6 2023
End Date
July 30 2024
Last Update
September 29 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lancet Clinic
Moscow, Russia, 105066
2
IMSechenovMMA
Moscow, Russia, 119435